Logo-ia
ImmunoAnalysis. 2023;3: 6 | Published on: 2023 Jun 26. doi: 10.34172/ia.2023.06

Original Research

The Combination of PD-L1 and CTLA-4 Suppression Significantly Decreased the Expression Levels of Cancer Stem Cell Factors in the Pancreatic Cancer Cell Line

Nazila Alizadeh 1 ORCID, Tohid Kazemi 1,2, Nima Hemmat 1, Mahdi Jafarlou 1, Behzad Baradaran 1,2 * ORCID

Cited by CrossRef: 3

1- Aslan E, Akcali N, Yavas C, Eslamkhah S, Gur S, Karcioglu Batur L. Enhancing the Chemosensitivity of MKN-45 Gastric Cancer Cells to Docetaxel via B7H6 Suppression: A Novel Therapeutic Strategy. Life. 2024;14(12):1546 [Crossref]
2- Taghavi B, Salehi M, Mokhtarzadeh A, Baradaran B. Suppression of B7-H7 Enhanced MCF-7 Cancer Cell Line’s Chemosensitivity to Paclitaxel. Mol Biotechnol. 2024; [Crossref]
3- Hamidnia F, Aslan E, Najafi S, Baghbani E, Eslamkhah S, Baradaran B. Enhancing Chemotherapy Efficacy: Investigating the Synergistic Impact of Paclitaxel and cd73 Gene Suppression on Breast Cancer Cell Proliferation and Migration. 2024; [Crossref]
4- Ali S, Adnan Y, Ahmad Z, Chawla T, Ali S, Mahla R. Significant Association of PD‐L1 With CD44 Expression and Patient Survival: Avenues for Immunotherapy and Cancer Stem Cells Downregulation in Pancreatic Cancers. Journal of Cancer Epidemiology. 2024;2024(1) [Crossref]